Tektonidou MG, Andreoli L, Limper M et al (2019) EULAR recommendations for the management of antiphospholipid syndrome in adults. Ann Rheum Dis 78(10):1296–1304. https://doi.org/10.1136/annrheumdis-2019-215213

Article  CAS  PubMed  Google Scholar 

Garcia D, Erkan D (2018) Diagnosis and management of the antiphospholipid syndrome Longo DL, ed. N Engl J Med. 378(21):2010–2021. https://doi.org/10.1056/NEJMra1705454

Article  CAS  PubMed  Google Scholar 

Schreiber K, Sciascia S, de Groot PG et al (2018) Antiphospholipid syndrome. Nat Rev Dis Prim 4(1):17103. https://doi.org/10.1038/nrdp.2017.103

Article  PubMed  Google Scholar 

Miyakis S, Lockshin MD, Atsumi T et al (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4(2):295–306. https://doi.org/10.1111/j.1538-7836.2006.01753.x

Article  CAS  PubMed  Google Scholar 

Lockshin MD (2013) Anticoagulation in management of antiphospholipid antibody syndrome in pregnancy. Clin Lab Med 33(2):367–376. https://doi.org/10.1016/j.cll.2013.01.001

Article  PubMed  PubMed Central  Google Scholar 

Kutteh WH (1996) Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. Am J Obstet Gynecol 174(5):1584–1589. https://doi.org/10.1016/s0002-9378(96)70610-5

Article  CAS  PubMed  Google Scholar 

Kutteh WH, Ermel LD (1996) A clinical trial for the treatment of antiphospholipid antibody-associated recurrent pregnancy loss with lower dose heparin and aspirin. Am J Reprod Immunol 35(4):402–407. https://doi.org/10.1111/j.1600-0897.1996.tb00501.x

Article  CAS  PubMed  Google Scholar 

Rai R, Cohen H, Dave M, Regan L (1997) Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). BMJ 314(7076):253–257. https://doi.org/10.1136/bmj.314.7076.253

Article  CAS  PubMed  PubMed Central  Google Scholar 

Farquharson RG, Quenby S, Greaves M (2002) Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment. Obstet Gynecol 100(3):408–413. https://doi.org/10.1016/s0029-7844(02)02165-8

Article  CAS  PubMed  Google Scholar 

Laskin CA, Spitzer KA, Clark CA et al (2009) Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA trial. J Rheumatol 36(2):279–287. https://doi.org/10.3899/jrheum.080763)

Article  CAS  PubMed  Google Scholar 

Sammaritano LR, Bermas BL, Chakravarty EE et al (2020) 2020 American college of rheumatology guideline for the management of reproductive health in rheumatic and musculoskeletal diseases. Arthritis Rheumatol 72(4):529–556. https://doi.org/10.1002/art.41191

Article  PubMed  Google Scholar 

Cervera R, Serrano R, Pons-Estel GJ et al (2015) Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients. Ann Rheum Dis 74(6):1011–1018. https://doi.org/10.1136/annrheumdis-2013-204838

Article  CAS  PubMed  Google Scholar 

Lockshin MD, Kim M, Laskin CA et al (2012) Prediction of adverse pregnancy outcome by the presence of lupus anticoagulant, but not anticardiolipin antibody, in patients with antiphospholipid antibodies. Arthritis Rheum 64(7):2311–2318. https://doi.org/10.1002/art.34402

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ruffatti A, Tonello M, Visentin MS et al (2011) Risk factors for pregnancy failure in patients with anti-phospholipid syndrome treated with conventional therapies: a multicentre, case-control study. Rheumatology (Oxford) 50(9):1684–1689. https://doi.org/10.1093/rheumatology/ker139

Article  CAS  PubMed  Google Scholar 

Andreoli L, Bertsias GK, Agmon-Levin N et al (2017) EULAR recommendations for women’s health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome. Ann Rheum Dis 76(3):476–485. https://doi.org/10.1136/annrheumdis-2016-209770

Article  CAS  PubMed  Google Scholar 

Danowski A, de Azevedo MNL, de Souza Papi JA, Petri M (2009) Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus. J Rheumatol 36(6):1195–1199. https://doi.org/10.3899/jrheum.081194

Article  CAS  PubMed  Google Scholar 

Ruffatti A, Calligaro A, Hoxha A et al (2010) Laboratory and clinical features of pregnant women with antiphospholipid syndrome and neonatal outcome. Arthritis Care Res (Hoboken) 62(3):302–307. https://doi.org/10.1002/acr.20098

Article  CAS  PubMed  Google Scholar 

Devreese KMJ, Groot PG, Laat B et al (2020) Guidance from the scientific and standardization committee for lupus anticoagulant/antiphospholipid antibodies of the international society on thrombosis and haemostasis: update of the guidelines for lupus anticoagulant detection and interpretation. J Thromb Haemost 18(11):2828–2839. https://doi.org/10.1111/jth.15047

Article  CAS  PubMed  Google Scholar 

ACOG Committee Opinion No. 579 (2013) Definition of term pregnancy. Obstet Gynecol 122(5):1139–1140. https://doi.org/10.1097/01.AOG.0000437385.88715.4a

Article  Google Scholar 

Branch DW. IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy. 2017;Identifier: NCT03152058. https://clinicaltrials.gov/ct2/show/NCT03152058

Jeremic K, Stefanovic A, Dotlic J et al (2015) Neonatal outcome in pregnant patients with antiphospholipid syndrome. J Perinat Med. https://doi.org/10.1515/jpm-2014-0118

Article  PubMed  Google Scholar 

Wind M, Hendriks M, van Brussel BTJ et al (2021) Effectiveness of a multidisciplinary clinical pathway for women with systemic lupus erythematosus and/or antiphospholipid syndrome. Lupus Sci Med 8:e000472. https://doi.org/10.1136/lupus-2020-000472

Article  PubMed  PubMed Central  Google Scholar 

Stone S, Hunt BJ, Khamashta MA, Bewley SJ, Nelson-Piercy C (2005) Primary antiphospholipid syndrome in pregnancy: an analysis of outcome in a cohort of 33 women treated with a rigorous protocol. J Thromb Haemost 3(2):243–245. https://doi.org/10.1111/j.1538-7836.2005.01185.x

Article  CAS  PubMed  Google Scholar 

Abou-Nassar K, Carrier M, Ramsay T, Rodger MA (2011) The association between antiphospholipid antibodies and placenta mediated complications: A systematic review and meta-analysis. Thromb Res 128(1):77–85. https://doi.org/10.1016/j.thromres.2011.02.006

Article  CAS  PubMed  Google Scholar 

Saccone G, Berghella V, Maruotti GM et al (2017) Antiphospholipid antibody profile based obstetric outcomes of primary antiphospholipid syndrome: the PREGNANTS study. Am J Obstet Gynecol 216(5):525.e1-525.e12. https://doi.org/10.1016/j.ajog.2017.01.026

Article  CAS  PubMed  Google Scholar 

Chayoua W, Kelchtermans H, Gris J et al (2020) The (non-)sense of detecting anti-cardiolipin and anti-β2glycoprotein I IgM antibodies in the antiphospholipid syndrome. J Thromb Haemost 18(1):169–179. https://doi.org/10.1111/jth.14633

Article  CAS  PubMed  Google Scholar 

Bouvier S, Cochery-Nouvellon É, Lavigne-Lissalde G et al (2014) Comparative incidence of pregnancy outcomes in treated obstetric antiphospholipid syndrome: the NOH-APS observational study. Blood 123(3):404–413. https://doi.org/10.1182/blood-2013-08-522623

Article  CAS  PubMed  Google Scholar 

Empson MB, Lassere M, Craig JC, Scott JR (2005) Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant. Cochrane pregnancy and childbirth group, ed. Cochrane Database of Syst Rev. https://doi.org/10.1002/14651858.CD002859.pub2

Article  Google Scholar 

Shi T, Gu ZD, Diao Q-zhi (2021) Meta-analysis on aspirin combined with low-molecular-weight heparin for improving the live birth rate in patients with antiphospholipid syndrome and its correlation with d-dimer levels. Medicine 100(25):e26264. https://doi.org/10.1097/MD.0000000000026264

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mak A, Cheung MWL, Cheak AAC, Ho RCM (2010) Combination of heparin and aspirin is superior to aspirin alone in enhancing live births in patients with recurrent pregnancy loss and positive anti-phospholipid antibodies: a meta-analysis of randomized controlled trials and meta-regression. Rheumatology 49(2):281–288. https://doi.org/10.1093/rheumatology/kep373

Article  CAS  PubMed  Google Scholar 

Lu C, Liu Y, Jiang HL (2019) Aspirin or heparin or both in the treatment of recurrent spontaneous abortion in women with antiphospholipid antibody syndrome: a meta-analysis of randomized controlled trials. J Matern Fetal Neonatal Med 32(8):1299–1311. https://doi.org/10.1080/14767058.2017.1404979

Article  CAS  PubMed  Google Scholar 

Noble LS, Kutteh WH, Lashey N, Franklin RD, Herrada J (2005) Antiphospholipid antibodies associated with recurrent pregnancy loss: Prospective, multicenter, controlled pilot study comparing treatment with low-molecular-weight heparin versus unfractionated heparin. Fertil Steril 83(3):684–690. https://doi.org/10.1016/j.fertnstert.2004.11.002

Article  CAS  PubMed  Google Scholar 

Fouda UM, Sayed AM, Abdou AMA, Ramadan DI, Fouda IM, Zaki MM (2011) Enoxaparin versus unfractionated heparin in the management of recurrent abortion secondary to antiphospholipid syndrome. Int J Gynecol Obstet 112(3):211–215. https://doi.org/10.1016/j.ijgo.2010.09.010

Article  CAS  Google Scholar 

Abrahams VM, Chamley LW, Salmon JE (2017) Emerging treatment models in rheumatology: antiphospholipid syndrome and pregnancy: pathogenesis to translation: pathogenesis of obstetric APS. Arthritis Rheumatol 69(9):1710–1721. https://doi.org/10.1002/art.40136

Article  PubMed  PubMed Central  Google Scholar